(Q36834027)

16 August 2017

1 reference

title

Malignant pleural mesothelioma: current concepts in treatment (English)

1 reference

malignant pleural mesothelioma

16 August 2017

1 reference

Athanasios Tsiouris

1

1 reference

PubMed ID

17534390

16 August 2017

Robin K Walesby

series ordinal

2

1 reference

16 August 2017

1 June 2007

1 reference

Nature Clinical Practice Oncology

16 August 2017

1 reference

16 August 2017

4

1 reference

16 August 2017

6

1 reference

16 August 2017

344-352

1 reference

https://scigraph.springernature.com/pub.10.1038/ncponc0839

16 August 2017

0 references

cites work

Dosimetric verification for intensity-modulated radiotherapy of thoracic cancers using experimental and Monte Carlo approaches.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Asbestos catalyzes hydroxyl and superoxide radical generation from hydrogen peroxide

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Molecular pathogenesis of malignant mesothelioma and its relationship to simian virus 40.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Simian virus-40 large-T antigen binds p53 in human mesotheliomas.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Simian virus 40 infection in humans and association with human diseases: results and hypotheses

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Current surgical management of malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Current trends in the management of malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Surgically debulked malignant pleural mesothelioma: results and prognostic factors.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Malignant mesothelioma of the pleura. A prospective therapeutic study of 132 patients from 1981-1985

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

The management of malignant pleural mesothelioma; single centre experience in 10 years

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

The diagnosis, therapy and prognosis of diffuse malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Altered fractionation of hemithorax irradiation for pleural mesothelioma and failure patterns after treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Chemotherapy for malignant mesothelioma: from doxorubicin to vinorelbine

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: the MED trial.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Short-term treatment-related symptoms and quality of life: results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an EORTC Lung-Cancer Group and National Can

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Overview on ongoing or planned clinical trials in Europe

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: the Memorial Sloan-Kettering experience

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0839

7 January 2021

Identifiers

DOI

10.1038/NCPONC0839

1 reference

PubMed ID

17534390

Dimensions Publication ID

16 August 2017

0 references

1 reference

PubMed ID

17534390